Singapore, May 15, 2014 - - Novartis announced today, the launch of Jakavi, the first and only approved oral medication to treat patients suffering from myelofibrosis in Singapore, and across more than 50 countries.
http://ift.tt/1oGtD7s
http://ift.tt/1oGtD7s
No comments:
Post a Comment